SE9402422D0 - New beads for controlled release and a pharmaceutical preparation containing the same - Google Patents

New beads for controlled release and a pharmaceutical preparation containing the same

Info

Publication number
SE9402422D0
SE9402422D0 SE9402422A SE9402422A SE9402422D0 SE 9402422 D0 SE9402422 D0 SE 9402422D0 SE 9402422 A SE9402422 A SE 9402422A SE 9402422 A SE9402422 A SE 9402422A SE 9402422 D0 SE9402422 D0 SE 9402422D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
controlled release
pct
same
preparation containing
Prior art date
Application number
SE9402422A
Other languages
English (en)
Inventor
Hans Arwidsson
Lars Stubberud
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9402422A priority Critical patent/SE9402422D0/sv
Publication of SE9402422D0 publication Critical patent/SE9402422D0/sv
Priority to EP95926053A priority patent/EP0723434A1/en
Priority to HU9600575A priority patent/HUT75772A/hu
Priority to SK303-96A priority patent/SK30396A3/sk
Priority to PCT/SE1995/000676 priority patent/WO1996001621A1/en
Priority to CZ96731A priority patent/CZ73196A3/cs
Priority to JP8504247A priority patent/JPH09502738A/ja
Priority to BR9506026A priority patent/BR9506026A/pt
Priority to MX9600858A priority patent/MX9600858A/es
Priority to US08/464,773 priority patent/US5783215A/en
Priority to EE9600034A priority patent/EE03280B1/xx
Priority to CA002170526A priority patent/CA2170526A1/en
Priority to CN95190775A priority patent/CN1134108A/zh
Priority to PL95313386A priority patent/PL313386A1/xx
Priority to RU96107106A priority patent/RU2141822C1/ru
Priority to AU29936/95A priority patent/AU700949B2/en
Priority to NZ289947A priority patent/NZ289947A/en
Priority to TW084106118A priority patent/TW460300B/zh
Priority to IL11444895A priority patent/IL114448A/xx
Priority to ZA955545A priority patent/ZA955545B/xx
Priority to TR95/00822A priority patent/TR199500822A2/xx
Priority to NO960837A priority patent/NO960837D0/no
Priority to FI961056A priority patent/FI961056A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SE9402422A 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same SE9402422D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same
NZ289947A NZ289947A (en) 1994-07-08 1995-06-07 Controlled-release beads having an inert core having a coating comprising hydrophilic polymer and pharmaceutically active substances
EE9600034A EE03280B1 (et) 1994-07-08 1995-06-07 Pidurdatud vabanemisega ravimkuulikesed ja neid sisaldav ravimpreparaat
CN95190775A CN1134108A (zh) 1994-07-08 1995-06-07 用于控释的新颗粒及含有该颗粒的药物制剂
SK303-96A SK30396A3 (en) 1994-07-08 1995-06-07 Beads, method for producing them and a pharmaceutical preparation containing the same
PCT/SE1995/000676 WO1996001621A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
CZ96731A CZ73196A3 (en) 1994-07-08 1995-06-07 Novel balls for controlled release and pharmaceutical preparation in which said balls are contained
JP8504247A JPH09502738A (ja) 1994-07-08 1995-06-07 制御放出のための新規ビーズおよびそれらを含有する医薬製剤
BR9506026A BR9506026A (pt) 1994-07-08 1995-06-07 Pérolas de liberação controlada processo para a preparação das mesmas preparação farmacêutica processo para a fabricação da mesma uso das pérolas de liberação controlada e processo para o tratamento da hipertensão de edemas e da falha congestiva do coração
MX9600858A MX9600858A (es) 1994-07-08 1995-06-07 Nuevas perlas o globulos para liberacion controlada y una preparacion farmaceutica que contiene las mismas.
US08/464,773 US5783215A (en) 1994-07-08 1995-06-07 Pharmaceutical preparation
EP95926053A EP0723434A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
CA002170526A CA2170526A1 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
HU9600575A HUT75772A (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
PL95313386A PL313386A1 (en) 1994-07-08 1995-06-07 Novel pearls ensuring controllable drug release and pharmaceutic preparation containing them
RU96107106A RU2141822C1 (ru) 1994-07-08 1995-06-07 Новые гранулы для регулируемого высвобождения и фармацевтические препараты, содержащие такие гранулы
AU29936/95A AU700949B2 (en) 1994-07-08 1995-06-07 New beads for controlled release and a pharmaceutical preparation containing the same
TW084106118A TW460300B (en) 1994-07-08 1995-06-15 Controlled release beads, pharmaceutical compositions containing the same and process for the preparation of the same
IL11444895A IL114448A (en) 1994-07-08 1995-07-04 Beads for controlled release process for their preparation and a pharmaceutical preparation containing the same
ZA955545A ZA955545B (en) 1994-07-08 1995-07-04 New beads for controlled release and a pharmaceutical preparation containing the same
TR95/00822A TR199500822A2 (tr) 1994-07-08 1995-07-06 Kontrollü salinim icin yeni taneler ve bunlari iceren farmasötik bir müstahzar.
NO960837A NO960837D0 (no) 1994-07-08 1996-02-29 Nye kuler for regulert frigjöring og et farmasöytisk preparat inneholdende slike
FI961056A FI961056A (sv) 1994-07-08 1996-03-07 Nya pärlor för kontrollerad frisättning och farmaceutisk beredning innehållande desamma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same

Publications (1)

Publication Number Publication Date
SE9402422D0 true SE9402422D0 (sv) 1994-07-08

Family

ID=20394677

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402422A SE9402422D0 (sv) 1994-07-08 1994-07-08 New beads for controlled release and a pharmaceutical preparation containing the same

Country Status (23)

Country Link
US (1) US5783215A (sv)
EP (1) EP0723434A1 (sv)
JP (1) JPH09502738A (sv)
CN (1) CN1134108A (sv)
AU (1) AU700949B2 (sv)
BR (1) BR9506026A (sv)
CA (1) CA2170526A1 (sv)
CZ (1) CZ73196A3 (sv)
EE (1) EE03280B1 (sv)
FI (1) FI961056A (sv)
HU (1) HUT75772A (sv)
IL (1) IL114448A (sv)
MX (1) MX9600858A (sv)
NO (1) NO960837D0 (sv)
NZ (1) NZ289947A (sv)
PL (1) PL313386A1 (sv)
RU (1) RU2141822C1 (sv)
SE (1) SE9402422D0 (sv)
SK (1) SK30396A3 (sv)
TR (1) TR199500822A2 (sv)
TW (1) TW460300B (sv)
WO (1) WO1996001621A1 (sv)
ZA (1) ZA955545B (sv)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
CA2230748C (en) * 1997-03-14 2010-08-03 American Home Products Corporation Rapamycin formulations for oral administration
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
CO5070568A1 (es) 1998-05-22 2001-08-28 Eurand Internatrional Spa Proceso de aplicacion de capas y aparato para efectuarlo
SE9803871D0 (sv) * 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
DE19842753A1 (de) * 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
PT1227806E (pt) 1999-11-11 2005-10-31 Pfizer Health Ab Formulacao farmaceutica contendo tolterodina e sua utilizacao
US20040219208A1 (en) * 2001-08-03 2004-11-04 Ryu Kawamura Sustained-release medicines
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US7022342B2 (en) * 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
CN1674877A (zh) * 2002-06-07 2005-09-28 兰贝克赛实验室有限公司 控释的多单位药物释放系统
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
WO2004072061A1 (en) 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
WO2004105735A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Controlled release pharmaceutical compositions of tolterodine and processes for their preparation
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
ES2662903T3 (es) 2003-11-25 2018-04-10 Smithkline Beecham (Cork) Limited Base libre de carvedilol, sales, formas anhidras o solvato de la misma, composiciones farmacéuticas correspondientes, formulaciones de liberación controlada, y procedimientos de tratamiento o administración
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US11311490B2 (en) 2005-08-10 2022-04-26 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release
US20070141151A1 (en) * 2005-12-20 2007-06-21 Silver David I Lansoprazole orally disintegrating tablets
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2640094C (en) 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
US20070202172A1 (en) * 2006-02-24 2007-08-30 Tomer Gold Metoprolol succinate E.R. tablets and methods for their preparation
CN101453993A (zh) 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
TW200806282A (en) * 2006-05-05 2008-02-01 Wyeth Corp Solid dosage formulations
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PT3357496T (pt) 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
EP2068837A2 (en) * 2006-07-28 2009-06-17 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
JP5501956B2 (ja) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
EP2148683A4 (en) 2007-04-25 2012-09-12 Proventiv Therapeutics Llc METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE
CN101668532B (zh) 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
US20090017111A1 (en) * 2007-07-03 2009-01-15 Van Den Heuvel Dennie J M Tolterodine bead
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
CA2714996C (en) 2008-04-02 2020-04-07 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
JP2012500823A (ja) * 2008-08-29 2012-01-12 グラクソ グループ リミテッド １−イソプロピル−４−｛［４−（テトラヒドロ−２ｈ−ピラン−４−イルオキシ）フェニル］カルボニル｝ヘキサヒドロ−１ｈ−１，４−ジアゼピンまたはその塩を含んでなる剤形
US20140112995A1 (en) * 2009-07-31 2014-04-24 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
CA2769760A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
GB201417828D0 (en) 2014-10-08 2014-11-19 Cereno Scient Ab New methods and compositions
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
RU2744270C2 (ru) * 2015-12-28 2021-03-04 ЭсЭсПи КО., ЛТД., ДЖАПАН Прессованный фармацевтический препарат
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108272766B (zh) * 2018-03-21 2020-07-07 江苏四环生物制药有限公司 一种甲钴胺分散迟释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716041A (en) * 1984-02-10 1987-12-29 A/S Alfred Benzon Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
FR2610327B1 (fr) * 1987-01-30 1989-08-25 Charbonnages Ste Chimique Interpolymere composite a plusieurs couches, son procede de preparation, son application au renforcement de matrices thermoplastiques rigides et compositions renforcees correspondantes
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
EP0447168A3 (en) * 1990-03-16 1993-01-07 Yamanouchi Pharmaceutical Co. Ltd. Long acting granular pharmaceutical composition
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.

Also Published As

Publication number Publication date
HU9600575D0 (en) 1996-07-29
US5783215A (en) 1998-07-21
NO960837L (no) 1996-02-29
EP0723434A1 (en) 1996-07-31
ZA955545B (en) 1996-01-08
TW460300B (en) 2001-10-21
FI961056A0 (sv) 1996-03-07
JPH09502738A (ja) 1997-03-18
AU2993695A (en) 1996-02-09
FI961056A (sv) 1996-05-06
IL114448A0 (en) 1995-11-27
CZ73196A3 (en) 1996-08-14
NO960837D0 (no) 1996-02-29
PL313386A1 (en) 1996-06-24
WO1996001621A1 (en) 1996-01-25
CA2170526A1 (en) 1996-01-25
CN1134108A (zh) 1996-10-23
SK30396A3 (en) 1997-09-10
IL114448A (en) 1999-09-22
HUT75772A (en) 1997-05-28
RU2141822C1 (ru) 1999-11-27
BR9506026A (pt) 1997-10-14
TR199500822A2 (tr) 1996-06-21
NZ289947A (en) 1998-07-28
MX9600858A (es) 1997-06-28
EE03280B1 (et) 2000-08-15
AU700949B2 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
DK0775018T4 (da) Fremgangsmåde til fremstilling af katalysatorer af cobalt på aluminiumoxid
PT98571A (pt) Dispositivos para a libertacao controlada que utilizam membranas polimerizadas interfacialmente e de processos para a sua preparacao
DE68912899D1 (de) Kupplungsscheiben und Verfahren zu ihrer Herstellung.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
FI973522A0 (sv) Vattenhaltiga, lesitinbaserade lösgöringskompositioner och förfaranden för deras användning
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
MY112915A (en) Multiple unit tableted dosage form 1
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
DE3780226D1 (de) Neue pharmazeutische praeparate zur topischen applikation, verfahren zu ihrer herstellung und ihre verwendung.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
ATE211636T1 (de) Methode zum herstellen eines dentalproduktes
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
DE68904147D1 (de) Kronenetherverbindung und trennmittel.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
TR25269A (tr) SüBSTITüE EDILMIS BENZANILIDLER VE ILISKILI BENZILAMINLER, HAZIRLANMALARINA MAHSUS USULLER VE HERBISID OLARAK KULLANIMLARI
NO901345L (no) Bindemiddel for anvendelse i stoeperier, samt fremgangsmaate for fremstilling av stoepekjerner og -former.
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
DE59004582D1 (de) 1,3-Di-arylmethoxy-4,6-dinitrobenzole, Verfahren zu ihrer Herstellung und Verfahren zur Herstellung von 4,6-Diaminoresorcin.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
DE69003986T2 (de) Hitze- und korrosionsbeständige, aus anorganischem Material zusammengetzte Körper und Verfahren zu ihrer Herstellung.
SE9404438D0 (sv) New process
NO885406L (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.